A newly developed immunotherapy that simultaneously uses modified immune-fighting cells to home in on and attack two antigens, or foreign substances, on cancer cells was highly effective in mice implanted with human neuroblastoma tissue, report researchers from the UNC Lineberger Comprehensive Cancer Center and the UNC School of Medicine.
Therapy using dual immune system cells effectively controls neuroblastoma
September 25, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022